Ismahane GUIMIOT | |
+33 (0)1 82 53 35 36 | |
[email protected] |
18 to 45 Years
Observational
Female
Unknown
The study consists in collecting umbilical cord blood cells from newborns at risk of sickle
cell disease, to perform laboratory experiments aiming to characterize the cells with HbS/HbS
mutation, to develop methods to prepare, to gene-modify and to preserve these cells.
– Pregnant women, giving birth at CHSF and consenting to the collect and study of
placental blood after delivery
– Age 18 to 45 years
– Biological testing of the participant includes hemoglobin electrophoresis and shows at
least one HbS allele
– Lack of written consent
– Minors (not 18 years old) or under guardianship
– Diseases : HIV, Hepatitis B, Hepatitis C or HTLV (Human T Leukemia Virus).